{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:00:35Z","timestamp":1773392435819,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tranon.2024.102030","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T23:34:12Z","timestamp":1718235252000},"page":"102030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["IL-6 knockdown in a model of the human bone marrow, abrogates DNA damage induction in bystander cells post-chemotherapy induced cytokine release syndrome"],"prefix":"10.1016","volume":"46","author":[{"given":"Harshini S.H.","family":"Asurappulige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Ladomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-0393","authenticated-orcid":false,"given":"H.","family":"Ruth Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2024.102030_bib0001","first-page":"1216","article-title":"Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1","volume":"25","author":"Ferrara","year":"1993","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.tranon.2024.102030_bib0002","doi-asserted-by":"crossref","unstructured":"Chatenoud, L., Ferran, C., Bach, J.F. The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. Curr. Top. Microbiol. Immunol.; 174: 121\u2013134.","DOI":"10.1007\/978-3-642-50998-8_9"},{"issue":"5","key":"10.1016\/j.tranon.2024.102030_bib0003","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciy530","article-title":"Sepsis and risk of cancer among elderly adults in the United States","volume":"68","author":"Liu","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tranon.2024.102030_bib0004","first-page":"3765","article-title":"Risk of malignant disease in 1-year sepsis survivors, a registry-based nationwide follow-up study","volume":"27","author":"H\u00e4stbacka","year":"2023","journal-title":"Crit. Care (Fullerton)"},{"issue":"1","key":"10.1016\/j.tranon.2024.102030_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.htct.2021.11.015","article-title":"Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature","volume":"44","author":"Costa","year":"2022","journal-title":"Hematol., Transfus. Cell Therapy"},{"key":"10.1016\/j.tranon.2024.102030_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biochi.2023.05.014","article-title":"Possible cancer-causing capacity of COVID-19: is SARS-CoV-2 an oncogenic agent?","volume":"213","author":"Jahankhani","year":"2023","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.tranon.2024.102030_bib0007","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2022.08.004","article-title":"The development of therapy related myeloid neoplasms in childhood cancer survivors","volume":"8","author":"Obeng","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tranon.2024.102030_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejca.2019.05.013","article-title":"Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: a cohort study within PanCareSurFup","volume":"117","author":"Allodji","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2024.102030_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145404","article-title":"Inflammasome modulation by chemotherapeutics in malignant mesothelioma","volume":"10","author":"Westbom","year":"2015","journal-title":"PLoS One;"},{"key":"10.1016\/j.tranon.2024.102030_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Therap."},{"issue":"5","key":"10.1016\/j.tranon.2024.102030_bib0011","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ccell.2020.09.019","article-title":"Cytokine storms in cancer and COVID-19","volume":"38","author":"Turnquist","year":"2020","journal-title":"Cancer Cell;"},{"key":"10.1016\/j.tranon.2024.102030_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-1161(96)00027-1","article-title":"Genetic toxicity of cytokines","volume":"361","author":"Lazutka","year":"1996","journal-title":"Mutat. Res."},{"issue":"5","key":"10.1016\/j.tranon.2024.102030_bib0013","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10408444.2020.1762541","article-title":"Inflammation, oxidative stress and genotoxicity responses to biodiesel emissions in cultured mammalian cells and animals","volume":"50","author":"M\u00f8ller","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"issue":"8","key":"10.1016\/j.tranon.2024.102030_bib0014","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/17435390.2019.1640908","article-title":"Inflammation and (secondary) genotoxicity of Ni and NiO nanoparticles","volume":"13","author":"\u00c5kerlund","year":"2019","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.tranon.2024.102030_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrrev.2018.08.001","article-title":"Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses","volume":"778","author":"Burdak-Rothkamm","year":"2018","journal-title":"Mutat. Res., Rev. Mutat. Res."},{"key":"10.1016\/j.tranon.2024.102030_bib0016","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.bbmt.2018.01.033","article-title":"Donor cell\u2013derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review","volume":"24","author":"Su\u00e1rez-Gonz\u00e1lez","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.tranon.2024.102030_bib0017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.exphem.2005.02.004","article-title":"Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation","volume":"33","author":"Rieger","year":"2005","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.tranon.2024.102030_bib0018","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/mutage\/gead018","article-title":"Genotoxicity of cytokines at chemotherapy-induced \u2018storm\u2019 concentrations in a model of the human bone marrow","volume":"38","author":"Asurappulige","year":"2023","journal-title":"Mutagenesis"},{"key":"10.1016\/j.tranon.2024.102030_bib0019","series-title":"Holland-Frei Cancer Medicine","author":"Hong","year":"2010"},{"key":"10.1016\/j.tranon.2024.102030_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00306744","article-title":"The clinical pharmacology of mitozantrone","volume":"17","author":"Smyth","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tranon.2024.102030_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00253059","article-title":"Pharmacokinetics of mitoxantrone in humans following single agent infusion or intra-arterial injection therapy or combined-agent infusion therapy","volume":"18","author":"Van Belle","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tranon.2024.102030_bib0022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mrgentox.2014.03.001","article-title":"Reduction of misleading (\"false\") positive results in mammalian cell genotoxicity assays. III: sensitivity of human cell types to known genotoxic agents","volume":"767","author":"Fowler","year":"2014","journal-title":"Mutat. Res. Genetic Toxicol. Environ. Mutagenesis"},{"key":"10.1016\/j.tranon.2024.102030_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/434010","article-title":"Cytokine levels in the serum of healthy subjects","author":"Kleiner","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.tranon.2024.102030_bib0024","first-page":"15","article-title":"Serum levels of tumor necrosis factor-\u03b1 and interleukins in children with congenital heart disease","volume":"12","author":"Noori","year":"2017","journal-title":"J. Tehran Univ. Heart Center"},{"issue":"10","key":"10.1016\/j.tranon.2024.102030_bib0025","doi-asserted-by":"crossref","first-page":"e45027","DOI":"10.1371\/journal.pone.0045027","article-title":"Dynamics of a cytokine storm","volume":"7","author":"Yiu","year":"2012","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.tranon.2024.102030_bib0026","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3324\/haematol.2011.053363","article-title":"Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Melenhorst","year":"2012","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.tranon.2024.102030_bib0027","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14789450.2020.1845654","article-title":"Multiomic analysis of cytokines in immune-oncology","volume":"17","author":"Jurisic","year":"2020","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.tranon.2024.102030_bib0028","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41598-021-82115-5","article-title":"Transforming early pharmaceutical assessment of genotoxicity: applying statistical learning to a high throughput, multi end point in vitro micronucleus assay","volume":"11","author":"Wilson","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2024.102030_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrgentox.2008.06.004","article-title":"Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test II: practical aspects with toxic agents","volume":"655","author":"Fellows","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tranon.2024.102030_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/mutage\/geac009","article-title":"A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing","volume":"37","author":"Vernon","year":"2022","journal-title":"Mutagenesis"},{"issue":"4","key":"10.1016\/j.tranon.2024.102030_bib0031","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","article-title":"Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 Genes","volume":"85","author":"Roecklein","year":"1995","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.tranon.2024.102030_bib0032","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00432-021-03854-6","article-title":"Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma","volume":"148","author":"Waldschmidt","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2024.102030_bib0033","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/00007890-199457110-00017","article-title":"Cytokine interactions in human mixed lymphocyte culture","volume":"57","author":"Danzer","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.tranon.2024.102030_bib0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.archoralbio.2016.10.012","article-title":"Saliva initiates the formation of pro-inflammatory macrophages in vitro","volume":"73","author":"Pourgonabadi","year":"2017","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.tranon.2024.102030_bib0035","unstructured":"Selleckchem website: resatorvid. Available at: https:\/\/www.selleckchem.com\/products\/resatorvid.html [accessed 1\/2\/24]."},{"issue":"5","key":"10.1016\/j.tranon.2024.102030_bib0036","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/1940-6207.CAPR-17-0349","article-title":"Pharmacological TLR4 antagonism using topical resatorvid blocks solar UV-induced skin tumorigenesis in SKH-1 mice","volume":"11","author":"Blohm-Mangone","year":"2018","journal-title":"Cancer Prevent. Res."},{"issue":"4","key":"10.1016\/j.tranon.2024.102030_bib0037","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/pharmaceutics14040700","article-title":"Design, physicochemical characterization, and in vitro permeation of innovative resatorvid topical formulations for targeted skin drug delivery","volume":"14","author":"Ruiz","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.tranon.2024.102030_bib0038","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1006\/cyto.1999.0491","article-title":"Induced heteroduplex genotyping of TNF-\u03b1, IL-l\u03b2, IL-6 and IL-10 polymorphisms associated with transcriptional regulation","volume":"11","author":"Morse","year":"1991","journal-title":"Cytokine"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324001578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324001578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T18:10:26Z","timestamp":1724868626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523324001578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":38,"alternative-id":["S1936523324001578"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102030","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 knockdown in a model of the human bone marrow, abrogates DNA damage induction in bystander cells post-chemotherapy induced cytokine release syndrome","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102030"}}